EndoCure

Private

IsraelHealthcare & Life Scienceshttps://endocure.tech/

Last Round

Seed

Jan 20, 2026

Total Funding Raised

$2.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EndoCure is a medical device company that develops an AI-powered robotic ultrasound platform for the detection, mapping, and monitoring of endometriosis and other medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Keywords

robotic ultrasoundmedical imagingfemtechmedtechmedical AIAI diagnostics3D ultrasoundendometriosis diagnosisdiagnostic imagingdigital healthAI-powered ultrasoundsurgical planningusage-based SaaSDICOMtelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EndoCure Comps

Public and private peers based on sector, stage, and business model.

EndoCure comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EndoCure Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jan 20, 2026
Pre Seed	Nov 30, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Hadas Ziso

Founder, CEO

Founding Team

EndoCure Investors

Notable investors and investment history

EndoCure investors
Investor	Rounds
Israel Innovation Authority	Pre Seed
Tech4Eva	Pre Seed
MassChallenge	Pre Seed
HiCenter	Pre Seed
Teuza	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2026
Completed a Seed funding round.
Jan 10, 2026
Grew 25% QoQ, from 12 to 15 employees.

View all signals

EndoCure Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

EndoCure Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EndoCure's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Employee Range17

Year Founded2023

Last FundingJan 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.